Presentation is loading. Please wait.

Presentation is loading. Please wait.

Advances In Flow cytometry Amina Kariminia Ph.D.

Similar presentations


Presentation on theme: "Advances In Flow cytometry Amina Kariminia Ph.D."— Presentation transcript:

1 Advances In Flow cytometry Amina Kariminia Ph.D.
Oncology Lab, Child & Family Research Institute, Department of Pediatrics, Faculty of Medicine University of British Columbia ICIA 2014 Milad Tower, Tehran

2 Outlines A glance to multi-color flow cytometry
Tregs in whole blood sample Kinetic of NFkB phosphorylation in pre B-cell leukemia Monitoring immuno-suprressor drugs Multi-color flow cytometry for normal human B-cell sub-populations MIFlowCyt Introducing Cy-TOF: mass-cytometry

3

4 Types of controls Instrument set up control Gating controls
PMT voltage settings Compensation Gating controls Isotype controls FMO controls Biological controls Unstimulated samples Healthy donors

5 Fluorescence Minus One is not always an ideal control
FMO FMO quadrant copy/pasted CD4- quadrant setting

6

7 No FRET with proper panel of conjugated Abs
Gal-Ser tetramer CD3

8

9 Flow cytometry of rare populations
Minimal Residual Disease GFP PBL stem cells BM stem cells Tetramers: Ag specific T cells

10 Rare population & Flow cytometry Practical Considerations
Number of events should be increased for statistical accuracy 200,000-1,000,000 Proper controls Proper instrument setting

11 Intracellular staining
Cytokine & Phospho protein

12 Intracellular staining
Cytokines Type of stimulator Time point Type of protein transport inhibitor Level of production Background level Type of Fix/perm Color selection

13 Intracellular staining
TH1/2/17 Frozen PBMCs from healthy donors PMA/I stimulation for 6 hr , CO2 incubator In presence of monensin 6 color staining BD fix/perm 500,000 cells acquired

14 CD4 CD3 IL-4 IL-17 IFN-g IFN-g

15 Phospho-protein detection
Type of stimulator Time point Level of production Background level Type of Fix/perm Color selection

16 B-cell Acute lymphoblastic leukemia cell lines
Phospho-protein TLR2 ligand Pam2CSK Pre B-cell leukemia cell lines Phosphorylation of NFkB & degradation of IkB

17 Time 5 Time 0 Time 10 Time 20

18 Dose response curve and phospho-protein kinetic analysis
TLR1 TLR-2 TLR-6 Dose response curve and phospho-protein kinetic analysis TLR1 TLR-2 TLR-6 TLR1 TLR-2 TLR-6

19 B-cell acute lymphoblastic leukemia:
IL-7R expression Healthy control Ig Light chain B-ALL relapse IL-7Ra

20 YB-1 in acute lymphoblastic leukemia
Interruption of host immune system recognition By HLA-DO up-regulation/decreasing Ag-presentation Prevention of apoptosis by Survivin YB-1 Blocking the effect of cytotoxic drugs Through IL-7 signaling and multi-drug resistance -1 (MDR-1) up-regulation

21 Novel IL-7 signaling pathway in B-cell ALL Phosphorylation of YB-1
pYB-1 No IL-7 IL-7 stimulated CD19

22 Treg 6-color staining CD3-PECY7, CD4-PerCPCY5
Treg 6-color staining CD3-PECY7, CD4-PerCPCY5.5, CD25-PE, CD127-FITC, CD45RA-V450, FOXP3-AF647

23 Immunophenotyping on preserved whole blood sample using
Cyto-Chex BCT tube

24 B-cell Immunophenotyping

25 CD19+ (Pacific Blue) gated cells
Peripheral Blood Bone marrow IgD-FITC IgD-FITC CD10-APC CD27-PE CD27-PE

26 Whole blood Treg phenotyping using eBioscience Kit CD3-APCH7, CD4-AF700, CD25-PE, Helios-AF488, FOXP3-V450 CD3+CD4+ gated T cells Cyto-Chex tube EDTA tube

27 Treg phenotyping and drug monitoring of an unique IPEX case CD3-AF488, CD4-PerCPCy5.5, CD25-PE, CD127-BV421, FOXP3-AF647 HD IPEX CD25-PE FOXP3-AF647

28 CD25-PE HD IPEX CD127-BV421

29 Immuno-supressor Monitoring detection of surface CD69 up-regulation upon CD2 activation (IPEX patient) CD3+CD4+ gated T cells Un-stimulated Stimulated Corticosteroid Sirolimus

30 The Minimum Information about Flow cytometry Experiment (MIFlowCyt)
Ref: Cytometry part A 73A: 2008

31 Simplify cross-platform comparison and integration,
MIFlowCyt Simplify cross-platform comparison and integration,

32 MIFlowCyt Experimental overview: Purpose/goal hypothesis
Experiment variables Conclusions Quality control

33 MIFlowCyt Flow sample (specimen): Material Source/organism/location
Treatment Reagent/analyte/detector/reporter

34 MIFlowCyt Data presentation
Experimental and Sample Information: Experimental design Sample preparation reagents Fluorescent reagents Vendor Catalog number Clone

35 MIFlowCyt Data presentation
Data acquisition: Instrument configuration Instrument identification Fluidics configuration Optical configuration Electronic configuration

36 MIFlowCyt Data presentation
Flow plots Label both axis Fluorophore and antibody Scale obvious Total events

37 MIFlowCyt Data presentation
Flow plots Label both axis Fluorophore and antibody Scale obvious Total events

38 CyTOF: mass -cytometry

39

40 Bendall et al, Science, 2011

41

42 Child & Family Research Institute


Download ppt "Advances In Flow cytometry Amina Kariminia Ph.D."

Similar presentations


Ads by Google